Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Capital Employed (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Return on Capital Employed for 13 consecutive years, with 0.2% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 2.0% to 0.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.2% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.24% for FY2025, 6.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.2% at Niagen Bioscience, down from 0.27% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.27% in Q3 2025, with the low at 0.88% in Q2 2022.
  • Average Return on Capital Employed over 5 years is 0.24%, with a median of 0.18% recorded in 2023.
  • The sharpest move saw Return on Capital Employed fell -15bps in 2022, then surged 63bps in 2023.
  • Over 5 years, Return on Capital Employed stood at 0.65% in 2021, then increased by 11bps to 0.58% in 2022, then surged by 71bps to 0.17% in 2023, then surged by 204bps to 0.17% in 2024, then increased by 14bps to 0.2% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.2%, 0.27%, and 0.26% for Q4 2025, Q3 2025, and Q2 2025 respectively.